Anzeige
Mehr »
Montag, 29.06.2026 - Börsentäglich über 12.000 News
China kontrolliert Seltene Erden - Brasilien könnte die Antwort sein
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P46G | ISIN: SE0014428512 | Ticker-Symbol: 4P41
Tradegate
29.06.26 | 13:42
2,970 Euro
+4,43 % +0,126
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SURGICAL SCIENCE SWEDEN AB Chart 1 Jahr
5-Tage-Chart
SURGICAL SCIENCE SWEDEN AB 5-Tage-Chart
RealtimeGeldBriefZeit
2,9562,98013:54
2,9602,97813:54

Aktuelle News zur SURGICAL SCIENCE SWEDEN Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
21.05.Surgical Science Sweden AB: Report from the Annual General Meeting of Surgical Science Sweden AB (publ)251At Surgical Science Sweden AB (publ)'s Annual General Meeting today, the following, amongst other things, was decided: To adopt the company's and the group's income statements and balance sheets for...
► Artikel lesen
20.05.Surgical Science Sweden AB Bottom Line Retreats In Q19
20.05.Surgical Science Sweden AB: Interim report January - March 2026: A solid start to the year276First quarter 2025 (Jan-Mar) Net sales amounted to SEK 235.5 (250.7) million, a decrease of 6 percent compared with the corresponding period in the preceding year. Calculated in local currencies, sales...
► Artikel lesen
SURGICAL SCIENCE SWEDEN Aktie jetzt für 0€ handeln
25.04.Globaler Mega-Deal: Bioxyne und Aurora Cannabis könnten den Markt umkrempeln!
19.02.Surgical Science Sweden AB: Year-end report 2025: Profitability in line with financial targets466Fourth quarter 2025 (October - December)Net sales amounted to SEK 268.9 (251.5) million, an increase of 7 percent compared with the corresponding period in the preceding year. Calculated in local currencies...
► Artikel lesen
08.12.25Surgical Science Sweden AB: Surgical Science announces new financial targets and initiates the process of a listing transfer565Surgical Science today communicates new financial targets. Growth shall amount to 10-15% annually with an adjusted EBIT of at least 15%. The company estimates that the targets will be met in 2027. As...
► Artikel lesen
25.11.25Surgical Science Sweden AB: Intuitive cancels the MoU and reverts to existing agreements. Surgical Science estimates that this will have a negative impact on license revenues of around SEK 60-90 million in 2026, compared to 20251.357The Memorandum of Understanding (MoU) signed between the companies on January 15 this year did not turn into a signed legal agreement. As a consequence of this, Surgical Science will not reach the previously...
► Artikel lesen
13.11.25Surgical Science Sweden AB: Interim report January-September 2025: Progress in the right direction488Third quarter 2025 (July - September)Net sales amounted to SEK 263.6 (231.8) million, an increase of 14 percent compared with the corresponding period in the preceding year. Calculated in local currencies...
► Artikel lesen
07.08.25Surgical Science Sweden AB: Sales in the second quarter were weak, which together with large currency effects weighed on the result889According to the preliminary reporting, Surgical Science's sales for the second quarter amounted to approximately SEK 209 million, a decrease of 2% compared to the second quarter of 2024. For the various...
► Artikel lesen
9 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1